Rochester – January & February 2017

February 18th, 2017

Our guest was Ima Garcia from Bristol-Myers Squibb (BMS) who shared with us information regarding EMPLICITI™ (elotuzumab), an immune therapy used in combination with lenalidomide and dexamethasone for previously treated patients with myeloma.

January 17th, 2017

Dr. Wilson Gonsalves, Hematologist and Multiple Myeloma specialist from Mayo Clinic, provided updates from the American Society of Hematology meeting held in December.  He presented valuable information about transplant, current combination therapies and some ‘up-and-coming’ drugs.  I want to thank Dr. Gonsalves, on behalf of the group as well as myself, for sharing part of his Saturday with us.
 
Teresa
Advertisements
This entry was posted in Myeloma and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s